{"id":"https://openalex.org/W4387539313","doi":"https://doi.org/10.1016/j.breast.2023.103588","title":"Cost effectiveness of using trastuzumab biosimilars compared to trastuzumab original drugs to treat breast cancer in a hospital setting","display_name":"Cost effectiveness of using trastuzumab biosimilars compared to trastuzumab original drugs to treat breast cancer in a hospital setting","publication_year":2023,"publication_date":"2023-10-11","ids":{"openalex":"https://openalex.org/W4387539313","doi":"https://doi.org/10.1016/j.breast.2023.103588","pmid":"https://pubmed.ncbi.nlm.nih.gov/37857129","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10587754"},"language":"en","primary_location":{"id":"doi:10.1016/j.breast.2023.103588","doi":"https://doi.org/10.1016/j.breast.2023.103588","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.breast.2023.103588","pdf_url":"http://www.thebreastonline.com/article/S0960977623005647/pdf","source":{"id":"https://openalex.org/S181123643","display_name":"The Breast","issn_l":"0960-9776","issn":["0960-9776","1532-3080"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Breast","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://www.thebreastonline.com/article/S0960977623005647/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102847818","display_name":"\u00c9ric Barat","orcid":"https://orcid.org/0000-0001-5300-6244","observed_orcids":["https://orcid.org/0000-0001-5300-6244"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210105918","display_name":"Normandie Universit\u00e9","ror":"https://ror.org/01k40cz91","country_code":"FR","type":"education","lineage":["https://openalex.org/I4210105918"]},{"id":"https://openalex.org/I98702875","display_name":"Universit\u00e9 de Caen Normandie","ror":"https://ror.org/051kpcy16","country_code":"FR","type":"education","lineage":["https://openalex.org/I4210105918","https://openalex.org/I98702875"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Eric C. Barat","raw_affiliation_strings":["Department of Pharmacy, CHU Rouen, Normandie University, UNICAEN, Inserm, U1086, Caen, France. Electronic address: eric.barat@chu-rouen.fr","Department of Pharmacy, CHU Rouen, Normandie University, UNICAEN, Inserm, U1086, Caen, France"],"raw_orcid":"https://orcid.org/0000-0001-5300-6244","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, CHU Rouen, Normandie University, UNICAEN, Inserm, U1086, Caen, France. Electronic address: eric.barat@chu-rouen.fr","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210105918","https://openalex.org/I98702875"]},{"raw_affiliation_string":"Department of Pharmacy, CHU Rouen, Normandie University, UNICAEN, Inserm, U1086, Caen, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210105918","https://openalex.org/I98702875"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049730694","display_name":"Marianne Arrii","orcid":"https://orcid.org/0009-0001-3820-4127","observed_orcids":["https://orcid.org/0009-0001-3820-4127"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marianne L.E. Arrii","raw_affiliation_strings":["Department of Pharmacy, CHU Rouen, 76031, Rouen, Cedex, France"],"raw_orcid":"https://orcid.org/0009-0001-3820-4127","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, CHU Rouen, 76031, Rouen, Cedex, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004022616","display_name":"Annaelle Soubieux","orcid":"https://orcid.org/0000-0001-6230-0306","observed_orcids":["https://orcid.org/0000-0001-6230-0306"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annaelle Soubieux-Bourbon","raw_affiliation_strings":["Department of Pharmacy, CHU Rouen, 76031, Rouen, Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, CHU Rouen, 76031, Rouen, Cedex, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000171005","display_name":"Mika\u00ebl Daouphars","orcid":"https://orcid.org/0000-0002-0856-3292","observed_orcids":["https://orcid.org/0000-0002-0856-3292"]},"institutions":[{"id":"https://openalex.org/I4387152093","display_name":"Centre Henri Becquerel","ror":"https://ror.org/00whhby07","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210141925","https://openalex.org/I4387152093"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Mika\u00ebl Daouphars","raw_affiliation_strings":["Department of Pharmacy, Henri Becquerel Cancer Center, 76038, Rouen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Henri Becquerel Cancer Center, 76038, Rouen, France","institution_ids":["https://openalex.org/I4387152093"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029293557","display_name":"R\u00e9mi Varin","orcid":"https://orcid.org/0000-0002-8871-9102","observed_orcids":["https://orcid.org/0000-0002-8871-9102"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I62396329","display_name":"Universit\u00e9 de Rouen Normandie","ror":"https://ror.org/03nhjew95","country_code":"FR","type":"education","lineage":["https://openalex.org/I4210105918","https://openalex.org/I62396329"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"R\u00e9mi Varin","raw_affiliation_strings":["Department of Pharmacy, UNIROUEN, Inserm, U1234, CHU Rouen, Normandie University, Rouen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, UNIROUEN, Inserm, U1234, CHU Rouen, Normandie University, Rouen, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I62396329"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059607930","display_name":"Patrick R. Tilleul","orcid":"https://orcid.org/0000-0002-5202-7999","observed_orcids":["https://orcid.org/0000-0002-5202-7999"]},"institutions":[{"id":"https://openalex.org/I39804081","display_name":"Sorbonne Universit\u00e9","ror":"https://ror.org/02en5vm52","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Patrick R. Tilleul","raw_affiliation_strings":["AP-HP, Sorbonne Universit\u00e9- Piti\u00e9 Salp\u00eatri\u00e8re, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AP-HP, Sorbonne Universit\u00e9- Piti\u00e9 Salp\u00eatri\u00e8re, Paris, France","institution_ids":["https://openalex.org/I39804081","https://openalex.org/I4210097159"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5102847818"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210105918","https://openalex.org/I98702875"],"apc_list":{"value":2630,"currency":"USD","value_usd":2630},"apc_paid":{"value":2630,"currency":"USD","value_usd":2630},"fwci":0.4102,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.53027027,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"72","issue":null,"first_page":"103588","last_page":"103588"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.5116999745368958,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.5116999745368958,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.41600000858306885,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.04830000177025795,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab-biosimilar","display_name":"trastuzumab biosimilar","score":0.9559999704360962},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9520000219345093},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.925000011920929},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.871999979019165},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.8999999761581421},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.9700000286102295},{"id":"https://openalex.org/keywords/hospital-cost-reduction","display_name":"hospital cost savings","score":0.6629999876022339},{"id":"https://openalex.org/keywords/time-savings","display_name":"time savings","score":0.515999972820282},{"id":"https://openalex.org/keywords/prescription-optimization","display_name":"prescription optimization","score":0.6159999966621399},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7009999752044678},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.5809999704360962},{"id":"https://openalex.org/keywords/diagnosis-related-groups","display_name":"diagnosis-related groups","score":0.5460000038146973}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.95975661277771},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.8981248140335083},{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.7895121574401855},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.6615294218063354},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.578283965587616},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.46485841274261475},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.37381085753440857},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34869712591171265},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.336630642414093},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.24532699584960938},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000094703","descriptor_name":"Cost-Effectiveness Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1016/j.breast.2023.103588","doi":"https://doi.org/10.1016/j.breast.2023.103588","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.breast.2023.103588","pdf_url":"http://www.thebreastonline.com/article/S0960977623005647/pdf","source":{"id":"https://openalex.org/S181123643","display_name":"The Breast","issn_l":"0960-9776","issn":["0960-9776","1532-3080"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Breast","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10587754","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10587754","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10587754/pdf/main.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast","raw_type":"Text"},{"id":"pmid:37857129","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37857129","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast (Edinburgh, Scotland)","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-05744137v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-05744137","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The Breast, 2023, 72, pp.103588. ⟨10.1016/j.breast.2023.103588⟩","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:43f154eeeb8b4718a2a7a5ef3d5eb187","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/43f154eeeb8b4718a2a7a5ef3d5eb187","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Breast, Vol 72, Iss , Pp 103588- (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.breast.2023.103588","doi":"https://doi.org/10.1016/j.breast.2023.103588","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.breast.2023.103588","pdf_url":"http://www.thebreastonline.com/article/S0960977623005647/pdf","source":{"id":"https://openalex.org/S181123643","display_name":"The Breast","issn_l":"0960-9776","issn":["0960-9776","1532-3080"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Breast","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4387539313.pdf","grobid_xml":"https://content.openalex.org/works/W4387539313.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W1988149797","https://openalex.org/W2024903800","https://openalex.org/W2091276904","https://openalex.org/W2160675720","https://openalex.org/W2272567705","https://openalex.org/W2315066014","https://openalex.org/W2514361541","https://openalex.org/W2589872684","https://openalex.org/W2688564736","https://openalex.org/W2701164092","https://openalex.org/W2771254106","https://openalex.org/W2773709250","https://openalex.org/W2949358313","https://openalex.org/W2957283447","https://openalex.org/W2990995443","https://openalex.org/W3014403178","https://openalex.org/W3024598465","https://openalex.org/W3115637958"],"related_works":["https://openalex.org/W3168469872","https://openalex.org/W3161359744","https://openalex.org/W2773709250","https://openalex.org/W2914573828","https://openalex.org/W2621391008","https://openalex.org/W4393005719","https://openalex.org/W1999755524","https://openalex.org/W4243676040","https://openalex.org/W4292548548","https://openalex.org/W4388033124"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Subcutaneous":[1],"(SC)":[2],"drug":[3],"administration,":[4,26],"such":[5],"as":[6,107],"the":[7,15,21,38,50,122,167,176,198,210,215,225,231],"Herceptin\u00ae":[8,68,70,75],"in":[9,90,150,239,244],"an":[10,138],"oncology":[11],"day":[12],"hospital":[13,177],"reduces":[14],"administration":[16,93],"time":[17],"of":[18,23,40,52,66,141,153,189,204,212,227],"trastuzumab.":[19],"In":[20,133],"context":[22],"combination":[24,91,245],"therapy":[25,92,246],"this":[27],"time-saving":[28,188],"may":[29],"be":[30],"called":[31],"into":[32],"question.":[33],"The":[34,202],"challenge":[35],"posed":[36],"by":[37],"deployment":[39],"much":[41],"less":[42],"expensive":[43],"IV":[44,72,99,243],"biosimilar":[45,71],"forms":[46,100,103],"raises":[47],"questions":[48],"about":[49],"cost-effectiveness":[51],"SC":[53,102,238],"administration.":[54,247],"METHODS:":[55],"Using":[56],"data":[57],"from":[58,121],"a":[59,129,151,187,205],"french":[60],"Diagnostic":[61],"Related":[62],"Groups":[63],"regarding":[64],"prescriptions":[65],"intravenous":[67],"(HIV),":[69],"(BSIV),":[73],"and":[74,96,241],"subcutaneous":[76],"(HSC),":[77],"we":[78],"conducted":[79,115],"two":[80,119],"simulations.":[81],"This":[82,233],"simulation":[83],"involved":[84],"replacing":[85],"all":[86],"HSC":[87],"with":[88,101,186],"BSIV":[89],"(Simulation":[94,109],"1)":[95],"subsequently":[97],"substituting":[98],"only":[104],"when":[105,164],"prescribed":[106],"monotherapy":[108,240],"2).":[110],"A":[111],"cost-benefit":[112],"analysis":[113],"was":[114,137],"based":[116],"on":[117],"these":[118],"simulations,":[120],"hospital's":[123],"perspective,":[124],"for":[125,175],"Normandy's":[126],"population":[127],"over":[128],"1-year":[130],"timeframe.":[131],"RESULTS:":[132],"Simulation":[134,170],"1,":[135],"there":[136],"average":[139,173],"cost-saving":[140],"\u20ac12":[142],"per":[143,145,160,162,181,183,192,194],"patient":[144,161,182,193],"year,":[146,184],"but":[147],"it":[148],"resulted":[149],"loss":[152],"10140":[154],"min,":[155],"equivalent":[156],"to":[157,166,179,197,217,221,230],"10":[158],"min":[159,191],"year":[163,195],"compared":[165,196],"current":[168,199],"situation.":[169,200],"2":[171],"yielded":[172],"cost-savings":[174,220],"amounting":[178],"\u20ac51":[180],"along":[185],"67":[190],"CONCLUSIONS:":[201],"development":[203],"program":[206],"aimed":[207],"at":[208],"optimizing":[209],"prescription":[211],"Trastuzumab":[213],"holds":[214],"potential":[216],"deliver":[218],"significant":[219],"hospitals":[222],"while":[223],"enhancing":[224],"quality":[226],"service":[228],"provided":[229],"patients.":[232],"optimization":[234],"involves":[235],"using":[236],"H":[237],"BS":[242]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2023-10-12T00:00:00"}